Query

Active Filters

  • (-) PSI Laboratories = Center for Radiopharmaceutical Sciences ZRW
  • (-) PSI Authors ≠ Türler, Andreas
Search Results 1 - 20 of 339

Pages

  • RSS Feed
Select Page
Prostate-specific membrane antigen–targeted therapies for prostate cancer: towards improving therapeutic outcomes
Corpetti, M., Müller, C., Beltran, H., de Bono, J., & Theurillat, J. P. (2024). Prostate-specific membrane antigen–targeted therapies for prostate cancer: towards improving therapeutic outcomes. European Urology, 85(3), 193-204. https://doi.org/10.1016/j.eururo.2023.11.018
Terbium-149 production: a focus on yield and quality improvement towards preclinical application
Favaretto, C., Grundler, P. V., Talip, Z., Köster, U., Johnston, K., Busslinger, S. D., … van der Meulen, N. P. (2024). Terbium-149 production: a focus on yield and quality improvement towards preclinical application. Scientific Reports, 14(1), 3284 (12 pp.). https://doi.org/10.1038/s41598-024-53610-2
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([<sup>161</sup>Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
Fricke, J., Westerbergh, F., McDougall, L., Favaretto, C., Christ, E., Nicolas, G. P., … Wild, D. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06641-w
Matrix metalloproteinase-responsive delivery of PEGylated fibroblast growth factor 2
Gutmann, M., Reinhardt, D., Seidensticker, C., Raschig, M., Hahn, L., Moscaroli, A., … Lühmann, T. (2024). Matrix metalloproteinase-responsive delivery of PEGylated fibroblast growth factor 2. ACS Biomaterials Science & Engineering, 10(1), 156-165. https://doi.org/10.1021/acsbiomaterials.3c01511
Preclinical evaluation of gastrin-releasing peptide receptor antagonists labeled with <sup>161</sup>Tb and <sup>177</sup>Lu: a comparative study
Holzleitner, N., Cwojdzinski, T., Beck, R., Urtz-Urban, N., Hillhouse, C. C., Grundler, P. V., … Günther, T. (2024). Preclinical evaluation of gastrin-releasing peptide receptor antagonists labeled with 161Tb and 177Lu: a comparative study. Journal of Nuclear Medicine, 65(3), 481-484. https://doi.org/10.2967/jnumed.123.266233
Development of wide range photon detection system for muonic X-ray spectroscopy
Mizuno, R., Niikura, M., Saito, T. Y., Matsuzaki, T., Sakurai, H., Amato, A., … Wang, C. (2024). Development of wide range photon detection system for muonic X-ray spectroscopy. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 1060, 169029 (14 pp.). https://doi.org/10.1016/j.nima.2023.169029
High-resolution cross section measurements for neutron interactions on <sup>89</sup>Y with incident neutron energies up to 95 keV
Tagliente, G., Milazzo, P. M., Paradela, C., Kopecky, S., Vescovi, D., Alaerts, G., … Žugec, P. (2024). High-resolution cross section measurements for neutron interactions on 89Y with incident neutron energies up to 95 keV. European Physical Journal A: Hadrons and Nuclei, 60(1), 21 (18 pp.). https://doi.org/10.1140/epja/s10050-024-01243-4
Relaxed fibronectin: a potential novel target for imaging endometriotic lesions
Trachsel, B., Imobersteg, S., Valpreda, G., Singer, G., Grabherr, R., Ormos, M., … Béhé, M. (2024). Relaxed fibronectin: a potential novel target for imaging endometriotic lesions. EJNMMI Research, 14(1), 17 (11 pp.). https://doi.org/10.1186/s13550-024-01070-0
Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands
de Roode, K. E., Joosten, L., & Behe, M. (2024). Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands. Pharmaceuticals, 17(2), 256 (31 pp.). https://doi.org/10.3390/ph17020256
Results of the <sup>244</sup>Cm, <sup>246</sup>Cm and <sup>248</sup>Cm neutron-induced capture cross sections measurements at EAR1 and EAR2 of the n_TOF facility
Alcayne, V., Mendoza, E., Cano-Ott, D., Kimura, A., Aberle, O., Amaducci, S., … Žugec, P. (2023). Results of the 244Cm, 246Cm and 248Cm neutron-induced capture cross sections measurements at EAR1 and EAR2 of the n_TOF facility. In C. M. Mattoon, R. Vogt, J. Escher, & I. Thompson (Eds.), EPJ web conferences: Vol. 284. 15th international conference on nuclear data for science and technology (ND2022) (p. 01009 (6 pp.). https://doi.org/10.1051/epjconf/202328401009
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides
Beyer, D., Vaccarin, C., Deupi, X., Mapanao, A. K., Cohrs, S., Sozzi-Guo, F., … Müller, C. (2023). A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides. EJNMMI Research, 13(1), 32 (14 pp.). https://doi.org/10.1186/s13550-023-00979-2
The non-destructive investigation of a late antique knob bow fibula (Bügelknopffibel) from Kaiseraugst/CH using Muon Induced X-ray Emission (MIXE)
Biswas, S., Megatli-Niebel, I., Raselli, L., Simke, R., Cocolios, T. E., Deokar, N., … Amato, A. (2023). The non-destructive investigation of a late antique knob bow fibula (Bügelknopffibel) from Kaiseraugst/CH using Muon Induced X-ray Emission (MIXE). Heritage Science, 11, 43 (17 pp.). https://doi.org/10.1186/s40494-023-00880-0
Investigations using albumin binders to modify the tissue distribution profile of radiopharmaceuticals exemplified with folate radioconjugates
Busslinger, S. D., Becker, A. E., Vaccarin, C., Deberle, L. M., Renz, M. L., Groehn, V., … Müller, C. (2023). Investigations using albumin binders to modify the tissue distribution profile of radiopharmaceuticals exemplified with folate radioconjugates. Cancers, 15(17), 4259 (19 pp.). https://doi.org/10.3390/cancers15174259
Effect of zinc injection on mitigating stress corrosion cracking initiation of structural materials in light water reactor primary water
Chen, K., Mackiewicz, A., Virtanen, S., Grundler, P. V., Seifert, H. P., & Ritter, S. (2023). Effect of zinc injection on mitigating stress corrosion cracking initiation of structural materials in light water reactor primary water. Corrosion Reviews, 41(3), 387-398. https://doi.org/10.1515/corrrev-2022-0098
Determination of the half-life of gadolinium-148
Chiera, N. M., Dressler, R., Sprung, P., Talip, Z., & Schumann, D. (2023). Determination of the half-life of gadolinium-148. Applied Radiation and Isotopes, 194, 110708 (5 pp.). https://doi.org/10.1016/j.apradiso.2023.110708
Cross-section measurement of thulium radioisotopes with an 18 MeV medical PET cyclotron for an optimized <sup>165</sup>Er production
Dellepiane, G., Casolaro, P., Favaretto, C., Gottstein, A., Grundler, P. V., Mateu, I., … Braccini, S. (2023). Cross-section measurement of thulium radioisotopes with an 18 MeV medical PET cyclotron for an optimized 165Er production. Applied Radiation and Isotopes, 200, 110954 (11 pp.). https://doi.org/10.1016/j.apradiso.2023.110954
Copper nano-architecture topical cream for the accelerated recovery of burnt skin
Ermini, M. L., Summa, M., Zamborlin, A., Frusca, V., Mapanao, A. K., Mugnaioli, E., … Voliani, V. (2023). Copper nano-architecture topical cream for the accelerated recovery of burnt skin. Nanoscale Advances, 5(4), 1212-1219. https://doi.org/10.1039/d2na00786j
<sup>161</sup>Tb-DOTATOC production using a fully automated disposable cassette system: a first step toward the introduction of <sup>161</sup>Tb into the clinic
Favaretto, C., Grundler, P. V., Talip, Z., Landolt, S., Sepini, L., Köster, U., … van der Meulen, N. P. (2023). 161Tb-DOTATOC production using a fully automated disposable cassette system: a first step toward the introduction of 161Tb into the clinic. Journal of Nuclear Medicine, 64(7), 1138-1144. https://doi.org/10.2967/jnumed.122.265268
Targeting mTORC1 activity to improve efficacy of radioligand therapy in cancer
Grzmil, M., Wiesmann, F., Schibli, R., & Behe, M. (2023). Targeting mTORC1 activity to improve efficacy of radioligand therapy in cancer. Cancers, 15(1), 17 (12 pp.). https://doi.org/10.3390/cancers15010017
Synthesis and preclinical evaluation of radiolabeled [<sup>103</sup>Ru]BOLD-100
Happl, B., Brandt, M., Balber, T., Benčurová, K., Talip, Z., Voegele, A., … Mindt, T. L. (2023). Synthesis and preclinical evaluation of radiolabeled [103Ru]BOLD-100. Pharmaceutics, 15(11), 2626 (11 pp.). https://doi.org/10.3390/pharmaceutics15112626
 

Pages